CTSB and infection: To test whether the catalytic activity of cysteine proteases was necessary to the induction of TH2 responses during pre-patent schistosome infection, we treated infected IL-4-eGFP reporter (4get) mice with the cysteine protease inhibitor, K11777, beginning on the day of infection and continuing daily for four weeks.